Lv53
1140 积分 2025-08-18 加入
Risk factors and the effect of belimumab on flares during glucocorticoid tapering in systemic lupus erythematosus: A multicentre ANSWER-SLE cohort study
19天前
已完结
Comparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis
1个月前
已完结
Efficacy and safety of telitacicept as an add-on therapy for relapsing lupus nephritis: a retrospective cohort study
1个月前
已完结
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
1个月前
已完结
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
3个月前
已完结
Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study
7个月前
已完结
Incidence and Risk of Glucocorticoid‐Associated Adverse Effects in Patients With Rheumatoid Arthritis
7个月前
已完结
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
7个月前
已完结
皖公网安备34019202002308
